首站-论文投稿智能助手
典型文献
Discovery of small molecule Gαq/11 protein inhibitors against uveal melanoma
文献摘要:
Constitutively activated G proteins caused by specific mutations mediate the development of multiple malignancies.The mutated Gαq/11 are perceived as oncogenic drivers in the vast majority of uveal melanoma(UM)cases,making directly targeting Gαq/11 to be a promising strategy for combating UM.Herein,we report the optimization of imidazopiperazine derivatives as Gαq/11 inhibitors,and iden-tified GQ262 with improved Gαq/11 inhibitory activity and drug-like properties.GQ262 efficiently blocked UM cell proliferation and migration in vitro.Analysis of the apoptosis-related proteins,extracel-lular signal-regulated kinase(ERK),and yes-associated protein(YAP)demonstrated that GQ262 distinctly induced UM cells apoptosis and disrupted the downstream effectors by targeting Gαq/11 directly.Significantly,GQ262 showed outstanding antitumor efficacy in vivo with good safety at the testing dose.Collectively,our findings along with the favorable pharmacokinetics of GQ262 revealed that directly targeting Gαq/11 may be an efficient strategy against uveal melanoma.
文献关键词:
作者姓名:
Yang Ge;Jun-Jie Deng;Jianzheng Zhu;Lu Liu;Shumin Ouyang;Zhendong Song;Xiaolei Zhang;Xiao-Feng Xiong
作者机构:
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation,Guangdong Province Engineering Laboratory for Druggability and New Drugs Evaluation,School of Pharmaceutical Sciences,Sun Yat-sen University,Guangzhou 510006,China
引用格式:
[1]Yang Ge;Jun-Jie Deng;Jianzheng Zhu;Lu Liu;Shumin Ouyang;Zhendong Song;Xiaolei Zhang;Xiao-Feng Xiong-.Discovery of small molecule Gαq/11 protein inhibitors against uveal melanoma)[J].药学学报(英文版),2022(08):3326-3340
A类:
Constitutively,imidazopiperazine,GQ262
B类:
Discovery,small,molecule,inhibitors,against,uveal,melanoma,activated,proteins,caused,by,specific,mutations,mediate,development,multiple,malignancies,mutated,are,perceived,oncogenic,drivers,vast,majority,UM,cases,making,directly,targeting,be,promising,strategy,combating,Herein,report,optimization,derivatives,iden,tified,improved,inhibitory,activity,drug,like,properties,efficiently,blocked,proliferation,migration,vitro,Analysis,apoptosis,related,extracel,lular,signal,regulated,kinase,ERK,yes,associated,YAP,demonstrated,that,distinctly,induced,cells,disrupted,downstream,effectors,Significantly,showed,outstanding,antitumor,efficacy,vivo,good,safety,testing,dose,Collectively,our,findings,along,favorable,pharmacokinetics,revealed,may
AB值:
0.629832
相似文献
EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription
Xiaoqing Lu;Liwei An;Guangjian FanTi;Lijuan Zang;Weiyi Huang;Junjian Li;Jun Liu;Weiyu Ge;Yuwei Huang;Jingxuan Xu;Shaoqian Du;Yuan Cao;Tianhao Zhou;Huijing Yin;Li Yu;Shi Jiao;Hongxia Wang-State Key Laboratory of Oncogenes and Related Genes,Department of Oncology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Breast Surgery,Shanxi Cancer Hospital,Chinese Academy of Medical Sciences,Taiyuan,Shanxi,China;Department of Medical Ultrasound,Shanghai Tenth People's Hospital,Tongji University Cancer Center,School of Medicine,Tongji University,Shanghai,China;Precision Research Center for Refractory Diseases,Institute for Clinical Research,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Pathology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;State Key Laboratory of Membrane Biology,Tsinghua-Peking University Joint Center for Life Sciences,School of Life Science,Tsinghua University,Beijing,China;State Key Laboratory of Genetic Engineering,School of Life Sciences,Fudan University,Shanghai,China
Pharmacodynamic,pharmacokinetic,and phase 1a study of bisthianostat,a novel histone deacetylase inhibitor,for the treatment of relapsed or refractory multiple myeloma
Yu-bo Zhou;Yang-ming Zhang;Hong-hui Huang;Li-jing Shen;Xiao-feng Han;Xiao-bei Hu;Song-da Yu;An-hui Gao;Li Sheng;Ming-bo Su;Xiao-li Wei;Yue Zhang;Yi-fan Zhang;Zhi-wei Gao;Xiao-yan Chen;Fa-jun Nan;Jia Li;Jian Hou-National Center for New Drug Screening,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Yantai Key Laboratory of Nanomedicine&Advanced Preparations,Yantai Institute of Materia Medica,Yantai 264000,China;Department of Hematology,Renji Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200127,China;Shanghai Center for Drug Metabolism and Pharmacokinetics Research,Shanghai 201203,China
Discovery of novel MIF inhibitors that attenuate microglial inflammatory activation by structures-based virtual screening and in vitro bioassays
Yu Zhang;Lei Xu;Yao Zhang;Jie Pan;Pu-qing Wang;Sheng Tian;Huan-ting Li;Bo-wen Gao;Ting-jun Hou;Xue-chu Zhen;Long-Tai Zheng-Department of Pharmacy,Hubei Clinical Research Center of Parkinson's disease,Xiangyang Key Laboratory of Movement Disorders,Xiangyang No.1 People'Hospital,Hubei University of Medicine,Xiangyang 441000,China;Institute of Bioinformatics and Medical Engineering,Jiangsu University of Technology,Changzhou 213001,China;Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences,Soochow University,Suzhou 215123,China;School of Pharmacy,Baotou Medical College,Baotou 014060,China;College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China
Identification of HMGCR as the anticancer target of physapubenolide against melanoma cells by in silico target prediction
Hai-yan Wang;Pian Yu;Xi-sha Chen;Hui Wei;Shi-jie Cao;Meng Zhang;Yi Zhang;Yong-guang Tao;Dong-sheng Cao;Feng Qiu;Yan Cheng-Department of Pharmacy,The Second Xiangya Hospital,Central South University,Changsha 410011,China;Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug,Changsha 410011,China;Xiangya School of Pharmaceutical Sciences,Central South University,Changsha 410008,China;School of Chinese Materia Medica and Tianjin State Key Laboratory of Modern Chinese Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;Department of Pharmacology,College of Pharmaceutical Sciences,Soochow University,Suzhou 215031,China;Key laboratory of Carcinogenesis and Cancer Invasion,Ministry of Education,Department of Pathology,Xiangya Hospital,School of Basic Medicine,Central South University,Changsha 410078,China;NHC Key laboratory of Carcinogenesis,Cancer Research Institute,Central South University,Changsha 410078,China
Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment
Da-cai Xu;Li Yang;Pei-quan Zhang;Ding Yan;Qian Xue;Qing-tian Huang;Xiao-fen Li;Ya-li Hao;Dao-lin Tang;Q.Ping Dou;Xin Chen;Jin-bao Liu-Affliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;The Department of Physiology,School of Basic Medical Sciences,Guizhou Medical University,Guiyang 550003,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
IMM-H007 attenuates isoprenaline-induced cardiac fibrosis through targeting TGFβ1 signaling pathway
Shuai-xing Wang;Ye-nan Feng;Shan Feng;Ji-min Wu;Mi Zhang;Wen-li Xu;You-yi Zhang;Hai-bo Zhu;Han Xiao;Er-dan Dong-Department of Cardiology and Institute of Vascular Medicine,Peking University Third Hospital,NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides,Key Laboratory of Molecular Cardiovascular Science,Ministry of Education,Beijing Key Laboratory of Cardiovascular Receptors Research,Beijing 100191,China;State Key Laboratory for Bioactive Substances and Functions of Natural Medicines,Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。